Bedaquiline, delamanid, linezolid, and clofazimine for rifampicin-resistant and fluoroquinolone-resistant tuberculosis (endTB-Q): an open-label, multicentre, stratified, non-inferiority, randomised, controlled, phase 3 trial - Guglielmetti, L; Khan, U; Velasquez, G E (Lancet Respir Med, 2025)
et al.